2024-10-15 Zekkei Cosmos Co. Ltd HaiPress
TOKYO,Oct. 15,2024 -- Zekkei Properties announces todaythatithassoldthe HOSHINOYA Hütte Niseko development to a consortium formed by Tokyu Land Corporation,Mitsubishi Estate Residence.,Ltd. and SMFL MIRAI Partners Co.,Ltd.
Through its special purpose subsidiaryZekkei Cosmos Co.,Ltd.,Zekkei has partnered with Hoshino Resorts since 2020and has successfully completed the planning,design and civil works for this first condominium hotel under the prestigious HOSHINOYA brand. The necessary building approval for the project was secured in early 2024. The sale of this entire project enables the consortium to complete the project based on the existing design and planning. The construction started on Oct 14,2024 and is expected to complete in 2029.
Planning Outline:
Property Name: HOSHINOYA Hütte Niseko (provisional)
Location:Yamada 204-2,Kutchan,Abuta District,Hokkaido
Structure: Reinforcedconcretewithsomesteelstructures
Site area: 6,462.83 square meters
Total floor area: 14,870 square meters
Rooms: 62
Levels: 7 levels (5 above ground)
Operator:Hoshino Resorts
Architect:Azuma ArchitectandAssociatesCo.,Ltd.
About ZekkeiProperties
Zekkei Properties,headquartered in Tokyo,is an international developer specializing in luxury holiday and urban residences. The company has successfully delivered a diverse portfolio of high-end developments across Japan,Thailand,Hong Kong,and mainland China. Since 2005,Zekkei has been a pioneering developer in Hokkaido,completed and sold multiple award-winning holiday residences in Niseko and Furano. In recent years,Zekkei has redirected its focus towards urban areas,developing a number of ultra-luxurious private residences in Tokyo.
Mediaenquiries regarding this releaseE-mailinfo@zekkei-properties.com
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Diet Tips Daily